An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study by Peter Barlis, Evelyn

An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting

stent: a LEADERS trial sub-study

by Peter Barlis, Evelyn Regar, Patrick W. Serruys, Konstantinos Dimopoulos, Willem J. van der Giessen, Robert-Jan M. van Geuns, Giuseppe Ferrante, Simon Wandel, Stephan Windecker, Gerrit-Anne van Es, Pedro Eerdmans, Peter Jüni, and Carlo di

Mario

EHJVolume 31(2):165-176

January 14, 2010

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: [email protected]

Trial profile. ¶Two patients allocated to sirolimus-eluting stents and clinical follow-up only (two lesions) had a clinically indicated angiography and underwent optical coherence tomography;

*One patient allocated to biolimus-eluting stents (two lesions) had one lesion excluded from the analysis for technical reasons; †Two patients allocated to sirolimus-eluting stents (four lesions)

had one lesion excluded each from the analysis for technical reasons.

Peter Barlis et al. Eur Heart J 2010;31:165-176


Examples of optical coherence tomography findings.



Graphical representation of stent coverage in lesions.



Distribution of neointimal thickness.



Documents

An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study by Peter Barlis, Evelyn